BPA Call 36C24820A0028-36C24822N0132
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for the provision of molecular pathogen detection services. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents and tests. The $430,808.73 ceiling value contract has a firm fixed price pricing type and was awarded by the...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services. The contract, valued at $810,091.80, was awarded by the Veterans Health Administration (VHA) of the Department of Veterans Affairs (VA) under the VA's Veterans Integrated Service Network (VISN) 8. The contract is a BPA (Blanket Purchase Agreement) call against Biofire's General Services Administration (GSA) Federal Supply...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for a Blanket Purchase Agreement (BPA) call under their existing General Services Administration (GSA) Federal Supply Schedule 65-VII contract for in vitro diagnostics, reagents, and tests. The contract is with the Veterans Health Administration (VHA) within the Department of Veterans Affairs and has a ceiling value of $171,925.20. It is for the provision of...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a Blanket Purchase Agreement (BPA) call order to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $146,700 contract is for the provision of virus, bacteria, and parasite detection systems, including molecular diagnostic testing services and products, COVID-19 testing reagents and equipment, and maintenance services for Biofire systems. This award was made...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for $801,960.90 to provide "Molecular Pathogen Detection" services. The contract was awarded by the Veterans Health Administration (VHA), part of the Department of Veterans Affairs (VA), and is not set aside. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for...
- This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The contract, valued at $79,037.70, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to provide in-vitro reagents. The contract is a Blanket Purchase Agreement (BPA) call order under Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The...
- This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for the provision of MOLECULAR PATHOGEN DETECTION services. The $977,947.90 Firm Fixed Price contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) and its various Veterans Integrated Service Networks. The contract is a call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for...
- This is a federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The contract, valued at $798,120.00, is for MOLECULAR PATHOGEN DETECTION services and was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) through its Veterans Integrated Service Network (VISN) 8. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply...
- This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit biotechnology company, is for a Blanket Purchase Agreement (BPA) call under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The contract, valued at $164,342, is for molecular pathogen detection services and products, including COVID-19 testing reagents and equipment, to support the Department of Veterans Affairs (VA)...
- This federal contract award is for MOLECULAR PATHOGEN DETECTION services, awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing. The $297,073.80 contract is a Blanket Purchase Agreement (BPA) call issued against Biofire's GSA Federal Supply Schedule (FSS-65-VII) for in-vitro diagnostics, reagents, and tests. The award supports the VHA's procurement of Biofire's...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- V797D30085-36C24820A0028Blanket Purchase Agreement
- 36C24820A0028-36C24822N0132BPA Call
This federal contract award to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, is for molecular pathogen detection services. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's own General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. The award, valued at $171,925.20, is for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to procure Biofire's diagnostic testing capabilities on an as-needed basis. Biofire has previously received multiple federal contract and grant awards from VHA, the Defense Health Agency, Department of Health and Human Services Indian Health Service, and the Department of State for a variety of infectious disease testing products and services. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($4k) | 2/22/23 | |
| Not listed | Not listed | $171.9k | 10/24/21 |